These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37021699)

  • 1. Roadblocks and resilience: A qualitative study of the impact of pediatric tuberculosis on Tanzanian households and solutions from caregivers.
    Petros de Guex K; Augustino D; Mejan P; Gadiye R; Massong C; Lukumay S; Msoka P; Sariko M; Kimathi D; Vinnard C; Xie Y; Mmbaga B; Pfaeffle H; Geba M; Heysell SK; Mduma E; Thomas TA
    Glob Public Health; 2023 Jan; 18(1):2196569. PubMed ID: 37021699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households.
    Kilale AM; Pantoja A; Jani B; Range N; Ngowi BJ; Makasi C; Majaha M; Manga CD; Haule S; Wilfred A; Hilary P; Mahamba V; Nkiligi E; Muhandiki W; Matechi E; Mutayoba B; Nishkiori N; Ershova J
    BMC Public Health; 2022 Mar; 22(1):600. PubMed ID: 35351063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "I would watch her with awe as she swallowed the first handful": A qualitative study of pediatric multidrug-resistant tuberculosis experiences in Durban, South Africa.
    Misra S; Misra N; Seepamore B; Holloway K; Singh N; Ngozo J; Dlamini V; Radebe Z; Ndjeka NO; Furin J
    PLoS One; 2022; 17(9):e0274741. PubMed ID: 36112604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caregiver perspectives on TB case-finding and HIV clinical services for children diagnosed with TB in Tanzania.
    Emerson C; Ndakidemi E; Ngowi B; Medley A; Ng'eno B; Godwin M; Ntinginya N; Carpenter D; Kohi W; Modi S
    AIDS Care; 2020 Apr; 32(4):495-499. PubMed ID: 31550905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The socioeconomic burden of pediatric tuberculosis and role of child-sensitive social protection.
    Shah K; Nakafeero J; Kadota JL; Wambi P; Nanyonga G; Kiconco E; Deus A; Sekadde MP; Nabukenya-Mudiope MG; Tukamuhebwa HA; Mupere E; Mohanty S; Cattamanchi A; Wobudeya E; Shete PB; Jaganath D
    BMC Public Health; 2023 Nov; 23(1):2339. PubMed ID: 38007477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
    Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
    BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying costs contributing to catastrophic expenditure among TB patients registered under RNTCP in Delhi metro city in India.
    Sarin R; Vohra V; Singla N; Thomas B; Krishnan R; Muniyandi M
    Indian J Tuberc; 2019 Jan; 66(1):150-157. PubMed ID: 30797274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios.
    Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH
    Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.
    Rudgard WE; Evans CA; Sweeney S; Wingfield T; Lönnroth K; Barreira D; Boccia D
    PLoS Med; 2017 Nov; 14(11):e1002418. PubMed ID: 29112693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
    Fuady A; Houweling TAJ; Mansyur M; Richardus JH
    Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-driven solutions and resilience adapted by people with drug-resistant tuberculosis and their caregivers in Bengaluru and Hyderabad, India: a qualitative study.
    Nagarajan K; Kumarswamy K; Begum R; Panibatla V; Singarajipura A; Adepu R; Munjattu JF; Sellapan S; Arangba S; Goswami A; Swamickan R; Basha J; Dsouza PM; Muniyandi M
    Lancet Reg Health Southeast Asia; 2024 Mar; 22():100372. PubMed ID: 38420270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Household financial burden among multidrug-resistant tuberculosis patients in Guizhou province, China: A cross-sectional study.
    Wang Y; McNeil EB; Huang Z; Chen L; Lu X; Wang C; Chen H; Chongsuvivatwong V
    Medicine (Baltimore); 2020 Jul; 99(28):e21023. PubMed ID: 32664107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study.
    Franck C; Seddon JA; Hesseling AC; Schaaf HS; Skinner D; Reynolds L
    BMC Infect Dis; 2014 Aug; 14():426. PubMed ID: 25084990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study.
    Timire C; Kranzer K; Pedrazzoli D; Kavenga F; Kasozi S; Mbiba F; Bond V
    medRxiv; 2023 Feb; ():. PubMed ID: 36909482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "It's about time they taught us": a qualitative study evaluating the barriers to finding and screening child contacts under five at risk for TB in Gauteng Province, South Africa from the provider and caregiver perspectives.
    Munedzimwe F; Chetty-Makkan CM; Mukora R; Charalambous S; Turner K; Chihota V
    BMC Health Serv Res; 2023 Dec; 23(1):1415. PubMed ID: 38102646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.
    Wingfield T; Boccia D; Tovar M; Gavino A; Zevallos K; Montoya R; Lönnroth K; Evans CA
    PLoS Med; 2014 Jul; 11(7):e1001675. PubMed ID: 25025331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China.
    Yang T; Chen T; Che Y; Chen Q; Bo D
    BMC Public Health; 2020 Jun; 20(1):1009. PubMed ID: 32586305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What can dissaving tell us about catastrophic costs? Linear and logistic regression analysis of the relationship between patient costs and financial coping strategies adopted by tuberculosis patients in Bangladesh, Tanzania and Bangalore, India.
    Madan J; Lönnroth K; Laokri S; Squire SB
    BMC Health Serv Res; 2015 Oct; 15():476. PubMed ID: 26493155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia.
    Morishita F; Yadav RP; Eang MT; Saint S; Nishikiori N
    PLoS One; 2016; 11(9):e0162796. PubMed ID: 27611908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.
    Rupani MP; Cattamanchi A; Shete PB; Vollmer WM; Basu S; Dave JD
    Infect Dis Poverty; 2020 Oct; 9(1):144. PubMed ID: 33076969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.